CAS 132201-33-3

(2R,3S)-N-Benzoyl-3-phenylisoserin

Formel: C₁₆H₁₅NO₄

InChl: InChI=1S/C16H15NO4/c18-14(16(20)21)13(11-7-3-1-4-8-11)17-15(19)12-9-5-2-6-10-12/h1-10,13-14,18H,(H,17,19)(H,20,21)/t13-,14+/m0/s1

InChI Key: InChIKey=HYJVYOWKYPNSTK-UONOGXRCSA-N

SMILES: [C@@H](NC(=O)C1=CC=CC=C1)([C@H](C(O)=O)O)C2=CC=CC=C2

Synonyme:

• (2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoic acid
• (2R,3S)-3-(Benzoylamino)-2-hydroxy-3-phenylpropanoic acid
• (2R,3S)-3-(Benzoylamino)-2-hydroxy-3-phenylpropionic acid
• (2R,3S)-N-Benzoyl-3-phenylisoserine
• (αR,βS)-β-(Benzoylamino)-α-hydroxybenzenepropanoic acid
• Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (αR,βS)-
• Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, [R-(R*,S*)]-
• N-benzoyl-(3S,2R)-3-phenylisoserine
• benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (alphaR,betaS)-
• N-Benzoyl-(2R,3S)-3-phenylisoserine

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

N-Benzoyl-(2R,3S)-3-phenylisoserine

Formel: C₁₆H₁₅NO₄

Reinheit: ≥98%, 10 mM in DMSO

Molekulargewicht: 285.29

Ref: 54-BUP11873

Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (αR,βS)-

CAS: 132201-33-3

Formel: C₁₆H₁₅NO₄

Reinheit: 97%

Farbe und Form: Solid

Molekulargewicht: 285.2946

Ref: IN-DA0010DS

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

Molekulargewicht: 285.29

Ref: 7W-GM1874

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

Formel: C₁₆H₁₅NO₄

Reinheit: 95%~99%

Molekulargewicht: 285.299

Ref: BP-BP4345

(2R,3S)-3-(Benzoylamino)-2-hydroxy-3-phenylpropanoic Acid ((2R,3S)-N-Benzoyl-3-phenylisoserine)

Kontrolliertes Produkt

CAS: 132201-33-3

Formel: C₁₆H₁₅NO₄

Farbe und Form: Neat

Molekulargewicht: 285.29

Ref: 86-MM1489.06

Paclitaxel Side Chain Impurity 1

CAS: 132201-33-3

Formel: C₁₆H₁₅NO₄

Molekulargewicht: 285.30

Ref: 4Z-P-2832

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

N-Benzoyl-(2R,3S)-3-phenylisoserine (taxol side chain) is an intermediate in the preparation of potent anticancer drug Paclitaxel, used to study the location of

Formel: C₁₆H₁₅NO₄

Reinheit: 99.10%

Farbe und Form: White Solid

Molekulargewicht: 285.29

Ref: TM-T7054

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

N-Benzoyl-(2R,3S)-3-Phenylisoserine

Formel: C₁₆H₁₅NO₄

Reinheit: 97%

Molekulargewicht: 285.29

Ref: IN-DG41247

(2R,3S)-N-Benzoyl-3-phenyl Isoserine

Kontrolliertes Produkt

CAS: 132201-33-3

Impurity Paclitaxel Side Chain Impurity 1
Applications (2R,3S)-N-Benzoyl-3-phenylisoserine is an intermediate in the preparation of potent anticancer drug Paclitaxel (P132500) used to study the location of the binding sites. (2R,3S)-N-Benzoyl-3-phenylisoserine shows cytotoxic, antiviral and immunomodulatory activity. Paclitaxel Side Chain Impurity 1.
References Paal, K. et al.: Bioorg. Med. Chem., 15, 1323 (2007); Krawczyk, E. et al.: J. Pharm. Pharmacol., 57, 791 (2005);

Formel: C₁₆H₁₅NO₄

Farbe und Form: Neat

Molekulargewicht: 285.29

Ref: TR-B208550

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS: 132201-33-3

Ref: BE-RMCP002023

(2R,3S)-3-Benzamido-2-hydroxy-3-phenylpropanoic acid

CAS: 132201-33-3

Formel: C₁₆H₁₅NO₄

Reinheit: 98%

Molekulargewicht: 285.299

Ref: 10-F212819

Paclitaxel Impurity 52

CAS: 132201-33-3

Formel: C₁₆H₁₅NO₄

Molekulargewicht: 285.30

Ref: ST-EA-CP-P36012

N-Benzoyl-(2R,3S)-3-amino-2-hydroxy-3-phenyl-propionicacid

CAS: 132201-33-3

N-Benzoyl-(2R,3S)-3-amino-2-hydroxy-3-phenylpropionic acid (BAPA) is a substance that is used in the manufacture of various drugs. It is also a potent anticancer drug that can be used for the treatment of cancer. BAPA has been shown to be an effective chemotherapeutic agent against many types of cancer cells. This drug is synthesized through an asymmetric synthesis process and has been shown to have potent cytotoxic effects against cancer cells with low levels of glutathione peroxide reductase. BAPA also inhibits the growth of bacteria by hydrolyzing or oxidizing proteins or by binding to DNA and RNA.

Formel: C₁₆H₁₅NO₄

Reinheit: Min. 95%

Molekulargewicht: 285.29 g/mol

Ref: 3D-FB151111